Literature DB >> 9826650

Structural basis for efficient phosphorylation of 3'-azidothymidine monophosphate by Escherichia coli thymidylate kinase.

A Lavie1, N Ostermann, R Brundiers, R S Goody, J Reinstein, M Konrad, I Schlichting.   

Abstract

The crystal structures of Escherichia coli thymidylate kinase (TmpK) in complex with P1-(5'-adenosyl)-P5-(5'-thymidyl)pentaphosphate and P1-(5'-adenosyl)P5-[5'-(3'-azido-3'-deoxythymidine)] pentaphosphate have been solved to 2.0-A and 2.2-A resolution, respectively. The overall structure of the bacterial TmpK is very similar to that of yeast TmpK. In contrast to the human and yeast TmpKs, which phosphorylate 3'-azido-3'-deoxythymidine 5'-monophosphate (AZT-MP) at a 200-fold reduced turnover number (kcat) in comparison to the physiological substrate dTMP, reduction of kcat is only 2-fold for the bacterial enzyme. The different kinetic properties toward AZT-MP between the eukaryotic TmpKs and E. coli TmpK can be rationalized by the different ways in which these enzymes stabilize the presumed transition state and the different manner in which a carboxylic acid side chain in the P loop interacts with the deoxyribose of the monophosphate. Yeast TmpK interacts with the 3'-hydroxyl of dTMP through Asp-14 of the P loop in a bidentate manner: binding of AZT-MP results in a shift of the P loop to accommodate the larger substituent. In E. coli TmpK, the corresponding residue is Glu-12, and it interacts in a side-on fashion with the 3'-hydroxyl of dTMP. This different mode of interaction between the P loop carboxylic acid with the 3' substituent of the monophosphate deoxyribose allows the accommodation of an azido group in the case of the E. coli enzyme without significant P loop movement. In addition, although the yeast enzyme uses Arg-15 (a glycine in E. coli) to stabilize the transition state, E. coli seems to use Arg-153 from a region termed Lid instead. Thus, the binding of AZT-MP to the yeast TmpK results in the shift of a catalytic residue, which is not the case for the bacterial kinase.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9826650      PMCID: PMC24323          DOI: 10.1073/pnas.95.24.14045

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

2.  The bottleneck in AZT activation.

Authors:  A Lavie; I Schlichting; I R Vetter; M Konrad; J Reinstein; R S Goody
Journal:  Nat Med       Date:  1997-08       Impact factor: 53.440

3.  Synthetic inhibitors of adenylate kinases in the assays for ATPases and phosphokinases.

Authors:  P Feldhau; T Fröhlich; R S Goody; M Isakov; R H Schirmer
Journal:  Eur J Biochem       Date:  1975-09-01

4.  Fluorescence and NMR investigations on the ligand binding properties of adenylate kinases.

Authors:  J Reinstein; I R Vetter; I Schlichting; P Rösch; A Wittinghofer; R S Goody
Journal:  Biochemistry       Date:  1990-08-14       Impact factor: 3.162

5.  The closed conformation of a highly flexible protein: the structure of E. coli adenylate kinase with bound AMP and AMPPNP.

Authors:  M B Berry; B Meador; T Bilderback; P Liang; M Glaser; G N Phillips
Journal:  Proteins       Date:  1994-07

6.  Use of herpes simplex virus thymidine kinase to improve the antiviral activity of zidovudine.

Authors:  N Guettari; L Loubière; E Brisson; D Klatzmann
Journal:  Virology       Date:  1997-09-01       Impact factor: 3.616

7.  Mechanism of adenylate kinase. Structural and functional roles of the conserved arginine-97 and arginine-132.

Authors:  T Dahnke; Z Shi; H Yan; R T Jiang; M D Tsai
Journal:  Biochemistry       Date:  1992-07-14       Impact factor: 3.162

8.  Structure at 1.65 A of RhoA and its GTPase-activating protein in complex with a transition-state analogue.

Authors:  K Rittinger; P A Walker; J F Eccleston; S J Smerdon; S J Gamblin
Journal:  Nature       Date:  1997-10-16       Impact factor: 49.962

9.  Crystal structure of yeast thymidylate kinase complexed with the bisubstrate inhibitor P1-(5'-adenosyl) P5-(5'-thymidyl) pentaphosphate (TP5A) at 2.0 A resolution: implications for catalysis and AZT activation.

Authors:  A Lavie; M Konrad; R Brundiers; R S Goody; I Schlichting; J Reinstein
Journal:  Biochemistry       Date:  1998-03-17       Impact factor: 3.162

10.  Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis.

Authors:  D E Coleman; A M Berghuis; E Lee; M E Linder; A G Gilman; S R Sprang
Journal:  Science       Date:  1994-09-02       Impact factor: 47.728

View more
  21 in total

1.  Coupling of NAD+ biosynthesis and nicotinamide ribosyl transport: characterization of NadR ribonucleotide kinase mutants of Haemophilus influenzae.

Authors:  Melisa Merdanovic; Elizabeta Sauer; Joachim Reidl
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

2.  Mechanisms of substrate selectivity for Bacillus anthracis thymidylate kinase.

Authors:  Cecilia Carnrot; Liya Wang; Dimitri Topalis; Staffan Eriksson
Journal:  Protein Sci       Date:  2008-06-03       Impact factor: 6.725

3.  Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generation.

Authors:  Jun Yong Choi; Mark S Plummer; Jeremy Starr; Charlene R Desbonnet; Holly Soutter; Jeanne Chang; J Richard Miller; Keith Dillman; Alita A Miller; William R Roush
Journal:  J Med Chem       Date:  2012-01-13       Impact factor: 7.446

4.  Thymidylate kinase of Mycobacterium tuberculosis: a chimera sharing properties common to eukaryotic and bacterial enzymes.

Authors:  H Munier-Lehmann; A Chaffotte; S Pochet; G Labesse
Journal:  Protein Sci       Date:  2001-06       Impact factor: 6.725

5.  Toxicity and tolerance mechanisms for azidothymidine, a replication gap-promoting agent, in Escherichia coli.

Authors:  Deani L Cooper; Susan T Lovett
Journal:  DNA Repair (Amst)       Date:  2010-12-10

6.  Engineering Kinases to Phosphorylate Nucleoside Analogs for Antiviral and Cancer Therapy.

Authors:  Stefan Lutz; Lingfeng Liu; Yichen Liu
Journal:  Chimia (Aarau)       Date:  2009-11-01       Impact factor: 1.509

7.  Automated docking with protein flexibility in the design of femtomolar "click chemistry" inhibitors of acetylcholinesterase.

Authors:  Garrett M Morris; Luke G Green; Zoran Radić; Palmer Taylor; K Barry Sharpless; Arthur J Olson; Flavio Grynszpan
Journal:  J Chem Inf Model       Date:  2013-03-29       Impact factor: 4.956

8.  Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine.

Authors:  Jia-Long Fang; Tao Han; Qiangen Wu; Frederick A Beland; Ching-Wei Chang; Lei Guo; James C Fuscoe
Journal:  Arch Toxicol       Date:  2013-11-30       Impact factor: 5.153

9.  Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent.

Authors:  Hélène Munier-Lehmann; Viviane Chenal-Francisque; Mihaela Ionescu; Petya Chrisova; Jeannine Foulon; Elisabeth Carniel; Octavian Bârzu
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

10.  Structures of S. aureus thymidylate kinase reveal an atypical active site configuration and an intermediate conformational state upon substrate binding.

Authors:  Masayo Kotaka; Balvinder Dhaliwal; Jingshan Ren; Charles E Nichols; Richard Angell; Michael Lockyer; Alastair R Hawkins; David K Stammers
Journal:  Protein Sci       Date:  2006-03-07       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.